Clinical trial
Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma
NCT07618793
Study timeline
Study start (estimated)2026-06-01Date precision: month
Registry last updated2026-06-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Squamous Cell Carcinomaunresolved
Carcinoma, Non-Small-Cell Lung (NSCLC)unresolved
Interventions
Standard Neoadjuvant Chemo-immunotherapyCOMBINATION_PRODUCT
Sponsors & collaborators
zhang yilead sponsor
Capital Medical Universitycollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07618793 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.